Set of diagnostic indicators for use in diagnosing breast cancer and method for in vitro diagnosis of breast cancer

PL451237A1Pending Publication Date: 2026-08-24GDANSKI UNIV MEDYCZNY
5 Cites 0 Cited by

Patent Information

Application Number
PL2025451237
Authority / Receiving Office
PL · PL
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-02-18
Publication Date
2026-08-24
Patent Text Reader

Abstract

The subject of the application is a set of diagnostic indicators containing glutamic acid, glutamine, glycine, tryptophan, proline, threonine, citrulline, aspartic acid and asparagine, for use in diagnosing breast cancer and a method for in vitro diagnosis of breast cancer.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Breast cancer diagnosis marker, screening method and quantification method thereof, and construction method and application of diagnosis model

    CN115932277A

  • Compound and organic light emitting device comprising the same

    KR102201553B1

  • Method for monitoring the process of acute lymphoblastic leukaemia by means of determination of amino acids

    PL419960A1

  • Biomarkers for assessing breast cancer

    WO2016038157A1

  • AU2013231188A1